- Absorbance-based assays assess activity of indispensable Schistosoma enzymes
- Effectiveness of new drugs and vaccines can be measured in live parasites and in real-time
- Absorbance-based microplate readers by BMG LABTECH reliably read the assay in endpoint and kinetic mode
Table of contents
Schistosomiasis is a parasitic disease that affects over 200 million people in tropical, developing nations, causing severe morbidity and over 300,000 deaths annually. Schistosomiasis is treated with a single drug and no vaccine is available.
New drugs and vaccines to control Schistosoma parasites can be developed by targeting mechanisms vital to the functioning of the organism and desirably result in impairment or, preferably, death of the parasite. Schistosomes possess a dynamic outer surface membrane called a tegument that mediates many of the parasites’ fundamental biological processes such as nutrient acquisition and immunity. Accordingly, molecules associated with the tegument have been a focus of schistosomiasis drug and vaccine development over the past few decades.
In this application note, we selected three Schistosoma surface-associated enzymes that are indispensable to parasitic survival: alkaline phosphatase1; phospho-diesterase SmNPP-52 and an acetylcholinesterase3. The activity of these molecules on the surface of live and intact larval and adult Schistosoma can be assayed in real time using cultured parasites, providing a tool to assess the efﬁcacy of drugs or vaccines targeting these enzymes.
The enzymes phosphodiesterase smNPP-5, alkaline phosphatase and acetylcholinesterase are essential for Schistosoma existence. Active enzymes cleave model substrates to chromophores (Fig. 1). Absorbance of the chromophores is measured to report on enzyme activity.
Materials & Methods
|Phosphodiesterase||Thymidine 5‘-monophosphate p-nitrophenyl ester (0.5 mM)|| |
50 mM Tris-HCl,
|Alkaline phosphatase||4-Nitrophenyl phosphate (2 mM)||0.1 M Glycine, |
1 mM MgCl2,
1 mM ZnCl2,
|Acetylcholinesterase||Acetylthiocholine (1 mM) 5,5‘-Dithiobis (2-nitrobenzoic acid) 0.5 mM|| |
0.1 M phosphate buffer,
Parasites were incubated in 0.5mL of enzyme-speciﬁc assay buffer (Table 1) in 48-well plates. Assays were performed in duplicate with various numbers of live larvae (schistosomula) (100, 200, 500, 1000, and 2000 per well) and adult worms (1, 2, 5 and 10 pairs per well) to estimate the number of parasite required for robust and reproducible results. Absorbance was measured with the FLUOstar Omega® and the following settings.
|Optic settings||Absorbance, plate mode kinetic|
|Wavelengths settings 405 nm|
|General settings||Number of flashes 20|
|Settling time 0.5 s|
|Kinetic settings||Number of cycles 68|
|Cycle time 900 s|
Results & Discussion
The kinetic data for acetylcholinesterase activity in live adult worms is depicted in Fig. 2 (conducted in duplicate). The rate of substrate processing increases with increasing worm number, all substrate being processed in two hours for 10 pairs of worms.
A plot of absorbance values at 1 hour for acetyl-cholinesterase activity (Fig. 3) demonstrates a linear relationship between enzyme activity and worm number. This suggests that each live worm has similar concentrations of acetylcholinesterase in its tegument. Similar results were obtained for Alkaline Phosphatase and Phosphodiesterase activity in adult worms (data not shown).
A linear relationship was also obtained for live schistosomula when they were incubated with substrates for the three enzymes. Absorbance values at 17 hours for Phosphodiesterase (Fig. 4A) and at 4 hours for Alkaline phosphatase (Fig. 4B) also show a linear relationship between the rate of substrate processing and somule number (data for acetylcholinesterase not shown).
This work establishes that adult schistosomes and the immature larvae can be used in a real-time assay for three crucial enzymes in the tegument of the parasites. This work will greatly aid in the screening and development of new drugs for the treatment of schistosomiasis. The work also highlights the versatility of the FLUOstar Omega microplate reader (BMG LABTECH) for the development of these assays and for drug development. Apart from ﬂuorescence and luminescence capabilities, the FLUOstar Omega is equipped with a robust absorbance spectrometer, allowing fast and reliable endpoint and kinetic absorbance data.
1. Sulbaran et al. (2013) Plos, Negl Trop Dis.
2. Bhardwaj et al. (2011) Infect Immun.
3. Arnon et al. (1987) Mem Inst Oswaldo Cruz